Mevo is a healthcare platform that provides digital prescription with online purchase option for medicines to be delivered to their homes.
Mevo has raised $18.2M in total funding. The most recent round was Series B. The last funding was announced in March 2026.
Mevo's investors include Matrix, Prosus, Floating Point, IKJ Capital, Matrix Partners.
Mevo is headquartered in São Paulo, Brazil.
Mevo is a healthcare platform that provides digital prescription with online purchase option for medicines to be delivered to their homes.
Mevo is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mevo — Funding & Investors." VCBacked, March 25, 2026, https://www.vcbacked.co/company/mevo. Accessed September 30, 2026.
VCBacked. (2026). Mevo — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mevo
{{cite web |title=Mevo — Funding & Investors |url=https://www.vcbacked.co/company/mevo |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated